RecruitingNCT05769621
A Retrospective Study to Characterize Participants With Propionic Acidemia
A Retrospective Cohort Study to Characterize Propionic Acidemia Patients
Sponsor
ModernaTX, Inc.
Enrollment
60 participants
Start Date
Jun 16, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA).
Eligibility
Min Age: 2 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with propionic acidemia. The study is currently recruiting participants at 29 locations. People eligible for this study include aged 2 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(29)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05769621
Related Trials
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
NCT028903422 locations
AAVrh10-PCCA Gene Therapy for Propionic Acidemia
NCT076438441 location
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
NCT0513043722 locations
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
NCT0415910335 locations
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
NCT050401785 locations